Search results

Skip to results

Area of interest

Area of interestCOVID-19 (1)

Type

TypeGuidance (105)News (6)NICE advice (4)Quality standards (1)Research recommendations (6)

Status

StatusAwaiting development (13)Discontinued (15)In consultation (1)In development (9)Published (61)Topic prioritisation (3)

Last updated

Last updatedLast 3 months (9)Last 6 months (11)Last year (17)Last 3 years (35)

Guidance programme

Guidance programmeClinical guidelines (8)Diagnostics guidance (2)HealthTech guidance (4)Highly specialised technologies guidance (1)NICE guidelines (8)Technology appraisal guidance (91)

Advice programme

Advice programmeEvidence summaries (1)Medtech innovation briefings (3)

Showing 136 to 136 of 136 results for myeloma

Sort by

People with a rare form of blood cancer are set to benefit after NICE recommends new targeted therapy
Hundreds of people with multiple myeloma could receive a new, targeted treatment recommended for use within the Cancer Drugs Fund today (Tuesday, 29 October).
Result type
News
Last updated
30 October 2024

Previous page
1
…
8
9
Current page 10
Page 10 of 10

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies